SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john dixon who wrote (2757)12/4/1998 10:06:00 AM
From: Tim K  Read Replies (1) of 3702
 
The Coulter deal would be sweet for Techniclone.
$41mil. cash upfront, although $7mil of it appears to be stock purchase. SBH pays for further development but royalties and profits are split 50%. $41mil is about 9% of their market cap., and has added about 9% to their share price.

I don't know if the same formula is transferrable to TCLN but with a market cap. of
~$70mil. it would add a bit to the share price.
Tim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News